1. Tripartite Motif‐Containing 27 Attenuates Liver Ischemia/Reperfusion Injury by Suppressing Transforming Growth Factor β–Activated Kinase 1 (TAK1) by TAK1 Binding Protein 2/3 Degradation
- Author
-
Jie Li, Ji-Hua Shi, Bo-Wen Hu, Shi Xiaoyi, Wang Zhihui, Shuijun Zhang, Huapeng Zhang, Yu-Ting He, Sanyang Chen, Yi Zhang, Hongwei Tang, Wen Peihao, Zhang Jiakai, Wenzhi Guo, and Yang Han
- Subjects
Male ,Biopsy ,Ubiquitin-Protein Ligases ,p38 mitogen-activated protein kinases ,Inflammation ,Cell Line ,Mice ,Liver Injury and Regeneration ,medicine ,Animals ,Humans ,RNA-Seq ,Adaptor Proteins, Signal Transducing ,Mice, Knockout ,Hepatology ,Chemistry ,Kinase ,Nuclear Proteins ,Original Articles ,MAP Kinase Kinase Kinases ,medicine.disease ,Liver Transplantation ,DNA-Binding Proteins ,Disease Models, Animal ,medicine.anatomical_structure ,Liver ,Apoptosis ,Reperfusion Injury ,Hepatocyte ,Proteolysis ,Knockout mouse ,Cancer research ,Original Article ,medicine.symptom ,Reperfusion injury ,Transforming growth factor - Abstract
Background and aims Hepatic ischemia-reperfusion (I/R) injury, which mainly involves inflammatory responses and apoptosis, is a common cause of organ dysfunction in liver transplantation (LT). As a critical mediator of inflammation and apoptosis in various cell types, the role of tripartite motif-containing (TRIM) 27 in hepatic I/R injury remains worthy of study. Approach and results This study systemically evaluated the putative role of TRIM27/transforming growth factor β-activated kinase 1 (TAK1)/JNK (c-Jun N-terminal kinase)/p38 signaling in hepatic I/R injury. TRIM27 expression was significantly down-regulated in liver tissue from LT patients, mice subjected to hepatic I/R surgery, and hepatocytes challenged by hypoxia/reoxygenation (H/R) treatment. Subsequently, using global Trim27 knockout mice (Trim27-KO mice) and hepatocyte-specific Trim27 transgenic mice (Trim27-HTG mice), TRIM27 functions to ameliorate liver damage, reduce the inflammatory response, and prevent cell apoptosis. In parallel in vitro studies, activating TRIM27 also prevented H/R-induced hepatocyte inflammation and apoptosis. Mechanistically, TRIM27 constitutively interacted with the critical components, TAK1 and TAK1 binding protein 2/3 (TAB2/3), and promoted the degradation of TAB2/3, leading to inactivation of TAK1 and the subsequent suppression of downstream JNK/p38 signaling. Conclusions TRIM27 is a key regulator of hepatic I/R injury by mediating the degradation of TAB2/3 and suppression of downstream TAK1-JNK/p38 signaling. TRIM27 may be a promising approach to protect the liver against I/R-mediated hepatocellular damage in transplant recipients.
- Published
- 2021
- Full Text
- View/download PDF